Spire Wealth Management Sangamo Therapeutics, Inc Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$5.23 - $7.82 $3,661 - $5,474	-700 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$7.29 - $10.97 $2,369 - $3,565	-325 Reduced 31.71%	700 $5,000
Q3 2021 Oct 22, 2021	SELL	$9.01 - $12.01 $3,604 - $4,804	-400 Reduced 28.07%	1,025 $9,000
Q2 2021 Jul 26, 2021	SELL	$10.17 - $12.64 $10,170 - $12,640	-1,000 Reduced 41.24%	1,425 $17,000
Q1 2021 May 21, 2021	BUY	$10.88 - $17.05 $26,384 - $41,346	2,425 New	2,425 $30,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.